Regeneron’s Gene Therapy DB-OTO Trial Shows Promising Hearing Improvement
Investigational gene therapy DB-OTO showed promising improvements in hearing and speech development in children with otoferlin-related genetic hearing loss.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
